Literature DB >> 20008692

Should there be a fracas over FRAX and other fracture prediction tools?: Comment on "A comparison of prediction models for fractures in older women".

Cathleen S Colón-Emeric1, Kenneth W Lyles.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 20008692      PMCID: PMC3743088          DOI: 10.1001/archinternmed.2009.2094

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  11 in total

Review 1.  FRAX and its applications to clinical practice.

Authors:  John A Kanis; Anders Oden; Helena Johansson; Fredrik Borgström; Oskar Ström; Eugene McCloskey
Journal:  Bone       Date:  2009-02-03       Impact factor: 4.398

2.  Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study.

Authors:  Eugene V McCloskey; Monique Beneton; Diane Charlesworth; Karthik Kayan; Dominic deTakats; Abhijit Dey; Jane Orgee; Robert Ashford; Martin Forster; Jennifer Cliffe; Linda Kersh; John Brazier; Jon Nichol; Sakari Aropuu; Tarja Jalava; John A Kanis
Journal:  J Bone Miner Res       Date:  2007-01       Impact factor: 6.741

3.  Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.

Authors:  M R McClung; P Geusens; P D Miller; H Zippel; W G Bensen; C Roux; S Adami; I Fogelman; T Diamond; R Eastell; P J Meunier; J Y Reginster
Journal:  N Engl J Med       Date:  2001-02-01       Impact factor: 91.245

4.  Does a history of non-vertebral fracture identify women without osteoporosis for treatment?

Authors:  Kathryn M Ryder; Steven R Cummings; Lisa Palermo; Suzanne Satterfield; Douglas C Bauer; Adrianne C Feldstein; John T Schousboe; Ann V Schwartz; Kristine Ensrud
Journal:  J Gen Intern Med       Date:  2008-05-06       Impact factor: 5.128

5.  Cost-effective osteoporosis treatment thresholds: the United States perspective.

Authors:  A N A Tosteson; L J Melton; B Dawson-Hughes; S Baim; M J Favus; S Khosla; R L Lindsay
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

6.  Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines.

Authors:  Meghan G Donaldson; Peggy M Cawthon; Li-Yung Lui; John T Schousboe; Kristine E Ensrud; Brent C Taylor; Jane A Cauley; Teresa A Hillier; Dennis M Black; Doug C Bauer; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

7.  Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.

Authors:  S R Cummings; D M Black; D E Thompson; W B Applegate; E Barrett-Connor; T A Musliner; L Palermo; R Prineas; S M Rubin; J C Scott; T Vogt; R Wallace; A J Yates; A Z LaCroix
Journal:  JAMA       Date:  1998 Dec 23-30       Impact factor: 56.272

8.  Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram.

Authors:  S K Sandhu; N D Nguyen; J R Center; N A Pocock; J A Eisman; T V Nguyen
Journal:  Osteoporos Int       Date:  2009-07-25       Impact factor: 4.507

9.  Case finding for the management of osteoporosis with FRAX--assessment and intervention thresholds for the UK.

Authors:  J A Kanis; E V McCloskey; H Johansson; O Strom; F Borgstrom; A Oden
Journal:  Osteoporos Int       Date:  2008-08-28       Impact factor: 4.507

10.  Effects of risedronate on fracture risk in postmenopausal women with osteopenia.

Authors:  E S Siris; J A Simon; I P Barton; M R McClung; A Grauer
Journal:  Osteoporos Int       Date:  2007-10-30       Impact factor: 4.507

View more
  3 in total

1.  Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women.

Authors:  E Y N Cheung; C H Bow; C L Cheung; C Soong; S Yeung; C Loong; A Kung
Journal:  Osteoporos Int       Date:  2011-05-12       Impact factor: 4.507

2.  WHO absolute fracture risk models (FRAX): do clinical risk factors improve fracture prediction in older women without osteoporosis?

Authors:  Teresa A Hillier; Jane A Cauley; Joanne H Rizzo; Kathryn L Pedula; Kristine E Ensrud; Douglas C Bauer; Li-Yung Lui; Kimberly K Vesco; Dennis M Black; Meghan G Donaldson; Erin S Leblanc; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2011-08       Impact factor: 6.741

3.  Exploration of the Immuno-Inflammatory Potential Targets of Xinfeng Capsule in Patients with Ankylosing Spondylitis Based on Data Mining, Network Pharmacology, and Molecular Docking.

Authors:  Yanyan Fang; Jian Liu; Ling Xin; Jianting Wen; Jinchen Guo; Dan Huang; Xu Li
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-23       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.